Decheng Capital LLC

Decheng Capital, LLC, established in 2011, specializes in venture-oriented investment strategies in the life sciences and healthcare sectors. The firm offers investment management services to private funds, focusing on early-stage life science companies and growth-stage healthcare firms. Decheng tailors its services to align with each fund's investment strategy, with approximately $2.1 billion in assets under management managed on a discretionary basis as of December 31, 2024. The firm charges management fees based on a percentage of commitments and costs of remaining investments, with fees reduced to zero after ten years. Decheng may receive carried interest or performance fees based on fund performance. The firm acts as a fiduciary, committed to acting in the best interests of its clients. Clients must be Qualified Purchasers with a minimum initial commitment of $5 million. Decheng's investment philosophy involves a concentrated portfolio of healthcare and life science companies, with a focus on long-term investments and risk management. The firm reviews client portfolios quarterly and votes on client securities' proxies in the clients' best interests. Decheng complies with the Custody Rule and maintains audited financial statements for clients. The firm does not engage in principal transactions with clients and has not faced any financial conditions impairing its commitments in the past ten years.